No Data
No Data
Express News | Alpha Tau Medical Ltd - Significant Reduction in Distant Pancreatic Cancer Tumor Growth Rate After First Tumor Is Treated With Alpha Dart Alone
Express News | Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at Estro 2024 Congress in Glasgow
Alpha Tau to Participate in May Investor Conferences
JERUSALEM, May 01, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, t
Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit
JERUSALEM, March 25, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW)), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT,
Buy Rating Affirmed: Anticipating Alpha Tau Medical's Clinical Milestones and Growth Potential in 2024
Express News | HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $9 Price Target